Associations - Herzuma (trastuzumab-pkrb)

HER-2 positive	Gastroesophageal Junction Adenocarcinoma	HER-2 positive	Gastroesophageal Junction Adenocarcinoma	trastuzumab-pkrb Sensitive: A1 - Approval trastuzumab-pkrb Sensitive : A1	trastuzumab-pkrb Sensitive: A1 - Approval trastuzumab-pkrb Sensitive : A1
HER-2 amplification	Hormone Receptor Positive Breast Cancer	HER-2 amplification	Hormone Receptor Positive Breast Cancer	trastuzumab-pkrb Sensitive: A1 - Approval trastuzumab-pkrb Sensitive : A1	trastuzumab-pkrb Sensitive: A1 - Approval trastuzumab-pkrb Sensitive : A1
HER-2 amplification	HER2 Positive Breast Cancer	HER-2 amplification	HER2 Positive Breast Cancer	trastuzumab-pkrb Sensitive: A1 - Approval trastuzumab-pkrb Sensitive : A1	trastuzumab-pkrb Sensitive: A1 - Approval trastuzumab-pkrb Sensitive : A1
HER-2 overexpression	Gastric Cancer	HER-2 overexpression	Gastric Cancer	trastuzumab-pkrb Sensitive: A1 - Approval trastuzumab-pkrb Sensitive : A1	trastuzumab-pkrb Sensitive: A1 - Approval trastuzumab-pkrb Sensitive : A1
HER-2 overexpression	Hormone Receptor Positive Breast Cancer	HER-2 overexpression	Hormone Receptor Positive Breast Cancer	trastuzumab-pkrb Sensitive: A1 - Approval trastuzumab-pkrb Sensitive : A1	trastuzumab-pkrb Sensitive: A1 - Approval trastuzumab-pkrb Sensitive : A1
HER-2 overexpression	HER2 Positive Breast Cancer	HER-2 overexpression	HER2 Positive Breast Cancer	trastuzumab-pkrb Sensitive: A1 - Approval trastuzumab-pkrb Sensitive : A1	trastuzumab-pkrb Sensitive: A1 - Approval trastuzumab-pkrb Sensitive : A1
HER-2 overexpression	Breast Cancer	HER-2 overexpression	Breast Cancer	trastuzumab-pkrb Sensitive: A1 - Approval trastuzumab-pkrb Sensitive : A1	trastuzumab-pkrb Sensitive: A1 - Approval trastuzumab-pkrb Sensitive : A1
HER-2 positive	HER2 Positive Breast Cancer	HER-2 positive	HER2 Positive Breast Cancer	trastuzumab-pkrb Sensitive: B - Late Trials trastuzumab-pkrb Sensitive : B	trastuzumab-pkrb Sensitive: B - Late Trials trastuzumab-pkrb Sensitive : B
HER-2 positive	Biliary Tract Cancer	HER-2 positive	Biliary Tract Cancer	trastuzumab-pkrb Sensitive: C1 - Off-label trastuzumab-pkrb Sensitive : C1	trastuzumab-pkrb Sensitive: C1 - Off-label trastuzumab-pkrb Sensitive : C1
HER-2 positive	Gastric Cancer	HER-2 positive	Gastric Cancer	trastuzumab-pkrb Sensitive: C1 - Off-label trastuzumab-pkrb Sensitive : C1	trastuzumab-pkrb Sensitive: C1 - Off-label trastuzumab-pkrb Sensitive : C1
HER-2 positive	Salivary Gland Cancer	HER-2 positive	Salivary Gland Cancer	trastuzumab-pkrb Sensitive: C1 - Off-label trastuzumab-pkrb Sensitive : C1	trastuzumab-pkrb Sensitive: C1 - Off-label trastuzumab-pkrb Sensitive : C1
HER-2 positive	Urothelial Cancer	HER-2 positive	Urothelial Cancer	trastuzumab-pkrb Sensitive: C1 - Off-label trastuzumab-pkrb Sensitive : C1	trastuzumab-pkrb Sensitive: C1 - Off-label trastuzumab-pkrb Sensitive : C1
ER negative	HER2 Positive Breast Cancer	ER negative	HER2 Positive Breast Cancer	pertuzumab + trastuzumab-pkrb Sensitive: C3 – Early Trials pertuzumab + trastuzumab-pkrb Sensitive : C3	pertuzumab + trastuzumab-pkrb Sensitive: C3 – Early Trials pertuzumab + trastuzumab-pkrb Sensitive : C3
PIK3CA E542Q	HER2 Positive Breast Cancer	PIK3CA E542Q	HER2 Positive Breast Cancer	PF-05212384 + trastuzumab-pkrb Sensitive: C3 – Early Trials PF-05212384 + trastuzumab-pkrb Sensitive : C3	PF-05212384 + trastuzumab-pkrb Sensitive: C3 – Early Trials PF-05212384 + trastuzumab-pkrb Sensitive : C3
PIK3CA amplification	HER2 Positive Breast Cancer	PIK3CA amplification	HER2 Positive Breast Cancer	PF-05212384 + trastuzumab-pkrb Sensitive: C3 – Early Trials PF-05212384 + trastuzumab-pkrb Sensitive : C3	PF-05212384 + trastuzumab-pkrb Sensitive: C3 – Early Trials PF-05212384 + trastuzumab-pkrb Sensitive : C3
PIK3CA N345K	HER2 Positive Breast Cancer	PIK3CA N345K	HER2 Positive Breast Cancer	PF-05212384 + trastuzumab-pkrb Sensitive: C3 – Early Trials PF-05212384 + trastuzumab-pkrb Sensitive : C3	PF-05212384 + trastuzumab-pkrb Sensitive: C3 – Early Trials PF-05212384 + trastuzumab-pkrb Sensitive : C3
PIK3CA E453K	HER2 Positive Breast Cancer	PIK3CA E453K	HER2 Positive Breast Cancer	PF-05212384 + trastuzumab-pkrb Sensitive: C3 – Early Trials PF-05212384 + trastuzumab-pkrb Sensitive : C3	PF-05212384 + trastuzumab-pkrb Sensitive: C3 – Early Trials PF-05212384 + trastuzumab-pkrb Sensitive : C3
PIK3CA H1047R	HER2 Positive Breast Cancer	PIK3CA H1047R	HER2 Positive Breast Cancer	PF-05212384 + trastuzumab-pkrb Sensitive: C3 – Early Trials PF-05212384 + trastuzumab-pkrb Sensitive : C3	PF-05212384 + trastuzumab-pkrb Sensitive: C3 – Early Trials PF-05212384 + trastuzumab-pkrb Sensitive : C3
PIK3CA E542K	HER2 Positive Breast Cancer	PIK3CA E542K	HER2 Positive Breast Cancer	PF-05212384 + trastuzumab-pkrb Sensitive: C3 – Early Trials PF-05212384 + trastuzumab-pkrb Sensitive : C3	PF-05212384 + trastuzumab-pkrb Sensitive: C3 – Early Trials PF-05212384 + trastuzumab-pkrb Sensitive : C3
PIK3CA H1047L	HER2 Positive Breast Cancer	PIK3CA H1047L	HER2 Positive Breast Cancer	PF-05212384 + trastuzumab-pkrb Sensitive: C3 – Early Trials PF-05212384 + trastuzumab-pkrb Sensitive : C3	PF-05212384 + trastuzumab-pkrb Sensitive: C3 – Early Trials PF-05212384 + trastuzumab-pkrb Sensitive : C3
HER-2 positive	HER2 Positive Breast Cancer	HER-2 positive	HER2 Positive Breast Cancer	pertuzumab + trastuzumab-pkrb Sensitive: C3 – Early Trials pertuzumab + trastuzumab-pkrb Sensitive : C3	pertuzumab + trastuzumab-pkrb Sensitive: C3 – Early Trials pertuzumab + trastuzumab-pkrb Sensitive : C3
HER-2 mutation	HER2 Positive Breast Cancer	HER-2 mutation	HER2 Positive Breast Cancer	trastuzumab-pkrb Resistant: C3 – Early Trials trastuzumab-pkrb Resistant : C3	trastuzumab-pkrb Resistant: C3 – Early Trials trastuzumab-pkrb Resistant : C3
PIK3CA mutation	HER2 Positive Breast Cancer	PIK3CA mutation	HER2 Positive Breast Cancer	trastuzumab-pkrb Resistant: C3 – Early Trials trastuzumab-pkrb Resistant : C3	trastuzumab-pkrb Resistant: C3 – Early Trials trastuzumab-pkrb Resistant : C3
HER-2 underexpression	Breast Cancer	HER-2 underexpression	Breast Cancer	trastuzumab-pkrb Sensitive: D – Preclinical trastuzumab-pkrb Sensitive : D	trastuzumab-pkrb Sensitive: D – Preclinical trastuzumab-pkrb Sensitive : D

Herzuma (trastuzumab-pkrb)

Associations
(24)

Associations
(24)

Herzuma (trastuzumab-pkrb)

Associations(24)

Associations(24)

Associations
(24)

Associations
(24)